Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Kinzler

Showing results (161-170 of 282) with videos related to

Pageof 29
Sort By:
Biorxiv : the Preprint Server for Biology|August 7, 2023
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Obstetrics and Gynecology|December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancerBritt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
BMC Medical Genomics|May 12, 2009
Identification of microbial DNA in human cancerChristopher G Duncan, Rebecca J Leary, Jimmy Cheng-Ho Lin, et al.
The Journal of Pathology|December 3, 2013
Whole-exome sequencing of pancreatic neoplasms with acinar differentiationYuchen Jiao, Raluca Yonescu, G Johan A Offerhaus, et al.
Magnetic Resonance in Medicine|October 15, 2013
Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRIGuanshu Liu, Chetan Bettegowda, Yuan Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
The colorectal microRNAomeJordan M Cummins, Yiping He, Rebecca J Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2021
Targeting loss of heterozygosity for cancer-specific immunotherapyMichael S Hwang, Brian J Mog, Jacqueline Douglass, et al.
JAMA|September 28, 2006
Prediction of germline mutations and cancer risk in the Lynch syndromeSining Chen, Wenyi Wang, Shing Lee, et al.
Pageof 29

Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|August 7, 2023
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.
Obstetrics and Gynecology|December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancerBritt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
BMC Medical Genomics|May 12, 2009
Identification of microbial DNA in human cancerChristopher G Duncan, Rebecca J Leary, Jimmy Cheng-Ho Lin, et al.
The Journal of Pathology|December 3, 2013
Whole-exome sequencing of pancreatic neoplasms with acinar differentiationYuchen Jiao, Raluca Yonescu, G Johan A Offerhaus, et al.
Magnetic Resonance in Medicine|October 15, 2013
Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRIGuanshu Liu, Chetan Bettegowda, Yuan Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
The colorectal microRNAomeJordan M Cummins, Yiping He, Rebecca J Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2021
Targeting loss of heterozygosity for cancer-specific immunotherapyMichael S Hwang, Brian J Mog, Jacqueline Douglass, et al.
JAMA|September 28, 2006
Prediction of germline mutations and cancer risk in the Lynch syndromeSining Chen, Wenyi Wang, Shing Lee, et al.
Pageof 29